|
|
||||||||
Department of Immunology/Microbiology, Rush Medical College, Chicago, IL 60612
Mannan-binding lectin (MBL) is a C1q-like molecule opsonic for several micro-organisms. MBL can activate C4, C2, and later acting complement components in the presence of serine proteases similar to but distinct from C1r and C1s via the lectin pathway of complement activation. We report here that mannan-coated MBL-sensitized erythrocytes are lysed via the lectin pathway in human serum-Mg-EGTA. The surprising occurrence of MBL-initiated lysis in the absence of calcium contrasts with the calcium requirement for C1q-initiated activation of C4 and C2. C2 is required, and lysis is significantly enhanced when indicator cells presensitized with C4 and then coated with mannan (EAC4-M) are used. The alternative pathway also is required, since lysis is lost when either factor D or factor B is removed and is restored upon reconstitution with the purified protein. Even though MBL is a C-type lectin, it is retained on mannan-coated erythrocytes in the absence of calcium. This contrasts with the absence of calcium-independent retention on mannan immobilized on polystyrene plates or beads, and helps explain the MBL-initiated hemolysis in Mg-EGTA. These investigations show that the alternative pathway as well as C4 and C2 of the classical pathway are required for complement-dependent hemolysis via the lectin pathway and provide a method for assay of lectin pathway-mediated complement activity in human serum that should be useful in unraveling the molecular interactions of this pathway.
This article has been cited by other articles:
![]() |
K. Goring, Y. Huang, C. Mowat, C. Leger, T.-H. Lim, R. Zaheer, D. Mok, L. A. Tibbles, D. Zygun, and B. W. Winston Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1140 - C1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Ma, N. Nakamura, V. Dlabac, H. Naito, S. Yamaguchi, M. Ishikawa, M. Nonaka, M. Ishiguro, N. Kawasaki, S. Oka, et al. Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum J. Biol. Chem., April 27, 2007; 282(17): 12963 - 12975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moller-Kristensen, S. Thiel, A. Sjoholm, M. Matsushita, and J. C. Jensenius Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway Int. Immunol., February 1, 2007; 19(2): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ji, G. G. Olinger, S. Aris, Y. Chen, H. Gewurz, and G. T. Spear Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization J. Gen. Virol., September 1, 2005; 86(9): 2535 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aoyagi, E. E. Adderson, J. G. Min, M. Matsushita, T. Fujita, S. Takahashi, Y. Okuwaki, and J. F. Bohnsack Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci J. Immunol., January 1, 2005; 174(1): 418 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Windbichler, B. Echtenacher, T. Hehlgans, J. C. Jensenius, W. Schwaeble, and D. N. Mannel Involvement of the Lectin Pathway of Complement Activation in Antimicrobial Immune Defense during Experimental Septic Peritonitis Infect. Immun., September 1, 2004; 72(9): 5247 - 5252. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Neth, D. L. Jack, M. Johnson, N. J. Klein, and M. W. Turner Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus J. Immunol., October 15, 2002; 169(8): 4430 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Undar, H. C. Eichstaedt, F. J. Clubb Jr, M. Fung, M. Lu, J. E. Bigley, W. K. Vaughn, and C. D. Fraser Jr Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass Ann. Thorac. Surg., August 1, 2002; 74(2): 355 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gulati, K. Sastry, J. C. Jensenius, P. A. Rice, and S. Ram Regulation of the Mannan-Binding Lectin Pathway of Complement on Neisseria gonorrhoeae by C1-Inhibitor and {alpha}2-Macroglobulin J. Immunol., April 15, 2002; 168(8): 4078 - 4086. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roos, L. H. Bouwman, D. J. van Gijlswijk-Janssen, M. C. Faber-Krol, G. L. Stahl, and M. R. Daha Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway J. Immunol., September 1, 2001; 167(5): 2861 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fung, P. G. Loubser, A. Undar, M. Mueller, C. Sun, W. N. Sun, W. K. Vaughn, and C. D. Fraser Jr Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saifuddin, M. L. Hart, H. Gewurz, Y. Zhang, and G. T. Spear Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1 J. Gen. Virol., April 1, 2000; 81(4): 949 - 955. [Abstract] [Full Text] |
||||
![]() |
E. Wagner, J. L. Platt, D. N. Howell, H. C. Marsh Jr., and M. M. Frank IgG and Complement-Mediated Tissue Damage in the Absence of C2: Evidence of a Functionally Active C2-Bypass Pathway in a Guinea Pig Model J. Immunol., September 15, 1999; 163(6): 3549 - 3558. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhong, T. Burns, Q. Chang, M. Carroll, and L. Pirofski Molecular and Functional Characteristics of a Protective Human Monoclonal Antibody to Serotype 8 Streptococcus pneumoniae Capsular Polysaccharide Infect. Immun., August 1, 1999; 67(8): 4119 - 4127. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |